Development and pre-clinical testing of a novel hypoxia-activated KDAC inhibitor-Reference-Cited by-同舟云学术

Development and pre-clinical testing of a novel hypoxia-activated KDAC inhibitor

Published:2021-09 Issue:9 Volume:28 Page:1258-1270.e13
ISSN:2451-9456
Container-title:Cell Chemical Biology
language:en
Short-container-title:Cell Chemical Biology

Author:

Skwarska Anna,Calder Ewen D.D.^ORCID,Sneddon Deborah,Bolland Hannah,Odyniec Maria L.^ORCID,Mistry Ishna N.,Martin Jennifer^ORCID,Folkes Lisa K.,Conway Stuart J.^ORCID,Hammond Ester M.^ORCID

Funder

EPSRC

MRC

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,Molecular Medicine,Biochemistry

Reference78 articles.

1. JNJ-26481585, a novel “second-generation” oral histone deacetylase inhibitor, shows broad-spectrum preclinical antitumoral activity;Arts;Clin. Cancer Res.,2009

2. Molecular pathways: hypoxia-activated prodrugs in cancer therapy;Baran;Clin. Cancer Res.,2017

3. Selective histone deacetylase 6 inhibitors bearing substituted urea linkers inhibit melanoma cell growth;Bergman;J. Med. Chem.,2012

4. Chemical phylogenetics of histone deacetylases;Bradner;Nat. Chem. Biol.,2010

5. CXXVIII.—the isomerism of the oximes. Part XXIX. Isomeric p-nitrobenzyl and methyl ethers of some aldoximes;Brady;J. Chem. Soc.,1927

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Soft drug inhibitors for the epigenetic targets lysine‐specific demethylase 1 and histone deacetylases;Archiv der Pharmazie;2024-07-14

2. A novel bioresponsive self-immolative spacer based on aza-quinone methide reactivity for the controlled release of thiols, phenols, amines, sulfonamides or amides;Chemical Science;2024

3. Disarming Gram-Negative Bacteria in the Fight Against Antimicrobial Resistance;ACS Central Science;2023-12-13

4. Metal‐Organic Framework‐Mediated Synergistic Hypoxia‐Activated Chemo‐Immunotherapy Induced by High Intensity Focused Ultrasound for Enhanced Cancer Theranostics;Small;2023-12-10

5. Design and synthesis of bioreductive prodrugs of class I histone deacetylase inhibitors and their biological evaluation in virally transfected acute myeloid leukemia cells;Archiv der Pharmazie;2023-11-06